News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
271,613 Results
Type
Article (14409)
Company Profile (281)
Press Release (256923)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (80641)
Career Advice (160)
Deals (13385)
Drug Delivery (35)
Drug Development (50497)
Employer Resources (31)
FDA (5762)
Job Trends (5255)
News (145824)
Policy (10097)
Tag
Academia (922)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21866)
ALS (69)
Alzheimer's disease (853)
Antibody-drug conjugate (ADC) (108)
Approvals (5788)
Artificial intelligence (134)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4651)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (232)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (161)
Cancer (1523)
Cardiovascular disease (120)
Career advice (141)
Career pathing (2)
CAR-T (123)
Cell therapy (340)
Cervical cancer (9)
Clinical research (41194)
Collaboration (562)
Compensation (277)
Complete response letters (13)
COVID-19 (1036)
CRISPR (44)
C-suite (172)
Cystic fibrosis (78)
Data (1612)
Denatured (11)
Depression (32)
Diabetes (144)
Diagnostics (1320)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (91)
Earnings (30676)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (49265)
Executive appointments (482)
FDA (6535)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (510)
Gene editing (102)
Generative AI (10)
Gene therapy (264)
GLP-1 (373)
Government (1095)
Grass and pollen (2)
Guidances (70)
Healthcare (6684)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (99)
Indications (20)
Infectious disease (1103)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (18)
IPO (7357)
IRA (11)
Job creations (888)
Job search strategy (133)
Kidney cancer (7)
Labor market (8)
Layoffs (214)
Leadership (3)
Legal (1411)
Liver cancer (34)
Lung cancer (207)
Lymphoma (103)
Machine learning (5)
Management (7)
Manufacturing (147)
MASH (63)
Medical device (2670)
Medtech (2671)
Mergers & acquisitions (6367)
Metabolic disorders (408)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (73)
Neuropsychiatric disorders (25)
Neuroscience (1278)
NextGen: Class of 2025 (2073)
Non-profit (913)
Now hiring (22)
Obesity (198)
Opinion (104)
Ovarian cancer (67)
Pain (45)
Pancreatic cancer (60)
Parkinson's disease (122)
Partnered (8)
Patents (135)
Patient recruitment (82)
Peanut (35)
People (25948)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14550)
Phase II (19164)
Phase III (12109)
Pipeline (936)
Policy (49)
Postmarket research (853)
Preclinical (6157)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (298)
Real estate (1455)
Recruiting (12)
Regulatory (8705)
Reports (16)
Research institute (951)
Resumes & cover letters (18)
Rett syndrome (5)
RNA editing (5)
RSV (10)
Schizophrenia (64)
Series A (99)
Series B (66)
Service/supplier (1)
Sickle cell disease (41)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1990)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (12)
The Weekly (37)
Vaccines (218)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (99)
Last 7 days (600)
Last 30 days (1797)
Last 365 days (19428)
2025 (7044)
2024 (20647)
2023 (22504)
2022 (26972)
2021 (27956)
2020 (23595)
2019 (16523)
2018 (12016)
2017 (13871)
2016 (11989)
2015 (14569)
2014 (10487)
2013 (7581)
2012 (7620)
2011 (7729)
2010 (7496)
Location
Africa (153)
Alabama (43)
Alaska (3)
Arizona (53)
Arkansas (6)
Asia (17400)
Australia (2962)
California (4070)
Canada (1175)
China (377)
Colorado (153)
Connecticut (158)
Delaware (111)
Europe (37897)
Florida (497)
Georgia (122)
Idaho (17)
Illinois (245)
India (10)
Indiana (97)
Iowa (3)
Japan (78)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (494)
Massachusetts (3233)
Michigan (74)
Minnesota (152)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (18)
New Hampshire (15)
New Jersey (1009)
New Mexico (12)
New York (1090)
North Carolina (570)
North Dakota (5)
Northern California (1813)
Ohio (115)
Oklahoma (9)
Oregon (21)
Pennsylvania (767)
Puerto Rico (6)
Rhode Island (20)
South America (215)
South Carolina (5)
Southern California (1562)
Tennessee (25)
Texas (475)
United States (13904)
Utah (56)
Virginia (83)
Washington D.C. (31)
Washington State (360)
Wisconsin (17)
271,613 Results for "iconic therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ICON Reports First Quarter 2025 Results
May 1, 2025
·
13 min read
Press Releases
ICON plc to Present at Upcoming Investor Conferences
March 5, 2025
·
2 min read
Business
ICON releases its ICON Cares 2023 Report
ICON plc, a world-leading healthcare intelligence and clinical research organisation, releases its ICON Cares 2023 Report.
May 9, 2024
·
5 min read
Press Releases
ICON plc Schedules First Quarter 2025 Earnings Conference Call
March 31, 2025
·
2 min read
Press Releases
Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies
May 7, 2025
·
3 min read
Press Releases
ICON Reports Fourth Quarter and Full Year 2024 Results
February 19, 2025
·
16 min read
Press Releases
ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies
January 30, 2025
·
4 min read
Press Releases
ICON Issues Financial Guidance for Full Year 2025
January 15, 2025
·
5 min read
ICON plc to Present at the 2024 Jefferies Global Healthcare Conference
ICON plc, a world-leading healthcare intelligence and clinical research organization, announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET.
June 4, 2024
·
2 min read
Press Releases
ICON Announces Appointment of Chief Operating Officer
December 18, 2024
·
3 min read
1 of 27,162
Next
